Elevated maternal soluble checkpoint molecules predict autoimmune congenital heart block
Year: 2024
Type: conference-paper
Abstract: Introduction: Type I interferon signature is a known risk factor for the development of autoimmune congenital heart block (CHB) after exposure to maternal anti-Ro/La autoantibodies [ref:1]. However, only about 2% of children born to mothers with the respective antibodies are affected, [for full text, please go to the a.m. URL]
DOI: 10.3205/24dgrh026
Authors: Stefanski, Ana-Luisa, Rincon-Arevalo, Hector, Nomovi, Nadja, Aue, Arman, Ritter, Jacob Casimir, Glenzer, Annika, Szelinski, Franziska, Schrezenmeier, Eva V., Lino, Andreia, Dörner, Thomas
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6946189286
FWCI:
Cites:
Cited by:
Related to:
